GlassScriptPhysician profile
Muhammad B Munir
NPI 1447505607
$62,958.63
in general payments reported to CMS, 2019-2025
9 companies · $1,978 in 2025
The $1,978 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11K · 2021: $31K · 2022: $6,174 · 2023: $7,502 · 2024: $4,855 · 2025: $1,978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,166 · Food and Beverage: $4,865 · Education: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,166.22 |
| Food and Beverage | $4,864.57 |
| Education | $304.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24,969.11 | 2021-2024 | Linq II, Tyrx |
| Abbott Laboratories | $15,909.99 | 2020-2024 | Aveir |
| Biotronik INC. | $13,246.76 | 2022-2025 | Acticor 7 Vr-T Dx, Selectra, Sentus |
| Boston Scientific Corporation | $8,111.25 | 2021-2025 | Cds - Mct/Cem Monitoring |
| Biosense Webster, INC. | $572.50 | 2022-2025 | Carto 3, Qdot Micro Catheter, Smartablatetm System Rf Generator |
| Cardiva Medical, INC. | $53.03 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Irhythm Technologies, INC. | $47.61 | 2024 | Zio Xt Patch, Zio Monitor |
| Philips North America LLC | $29.18 | 2020 | |
| Convatec INC. | $19.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Munir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.